Foghorn Therapeutics Inc. - Common Stock — Quarterly Cash Flow (NASDAQ:FHTX) | MetaTrader

Open full chart

Financials

Overview Statement Statistics

Quarterly Annual

Total assets 258.69 M226.24 M204.96 M198.1 M222.17 M Total liabilities 320.34 M302.89 M294.62 M306.6 M298.57 M Total equity -61.65 M-76.66 M-89.66 M-108.5 M-76.41 M Total liabilities & shareholders' equities 258.69 M226.24 M204.96 M198.1 M222.17 M Total debt ————— Net debt —————

News

Foghorn Therapeutics (FHTX) Surges 5.8%: Is This an Indication of Further Gains?

CorMedix (CRMD) Earnings Expected to Grow: What to Know Ahead of Next Week's Release

Foghorn Therapeutics Inc. (FHTX) Reports Q1 Loss, Lags Revenue Estimates

Sarepta Therapeutics (SRPT) Q1 Earnings and Revenues Top Estimates

Foghorn Therapeutics Inc. (FHTX) May Report Negative Earnings: Know the Trend Ahead of Q1 Release

Rhythm Pharmaceuticals, Inc. (RYTM) Reports Q1 Loss, Tops Revenue Estimates

Strength Seen in Dianthus Therapeutics, Inc. (DNTH): Can Its 5.6% Jump Turn into More Strength?

Citizens reiterates Foghorn Therapeutics stock rating on pipeline progress

Jefferies reiterates Foghorn Therapeutics stock rating on pipeline data

Stifel reiterates Foghorn Therapeutics stock rating at buy

Foghorn earnings missed by $0.02, revenue fell short of estimates

Foghorn Therapeutics Inc. (FHTX) Reports Q4 Loss, Beats Revenue Estimates